**AI医学成像新星AZmed斩获1500万欧元A轮融资**
法国医疗科技领域的初创公司AZmed近日宣布，其在A轮融资中成功筹集了1500万欧元，投资方包括知名金融机构Maison Worms、Techstars以及Tempact Ventures。这标志着这家致力于人工智能医学成像技术的公司在其发展道路上迈出了重要一步。
AZmed的核心产品是名为Rayvolve的AI软件，该软件被设计为一种诊断辅助工具，专用于识别标准放射照相中的各种异常情况。通过运用先进的人工智能算法，Rayvolve能够帮助放射科医生和急诊医生更快速、更准确地解读影像，从而提高医疗检查的效率，降低因人为因素导致的诊断错误风险。
据科技新闻平台Tech.eu报道，这笔资金将主要用于加速Rayvolve的技术研发和市场推广，同时扩大公司的服务范围，以满足全球医疗系统对高效、精准诊断工具日益增长的需求。AZmed的这一创新举措，预示着人工智能在医疗领域的应用将更加广泛，有望为医疗行业带来革命性的变化。
英语如下：
**AI Medical Imaging Startup AZmed Secures €15 Million in Funding, Pioneering Radiology Diagnostics Revolution**
Keywords: AZmed, AI medical imaging, €15 million funding
News Content: **AI Medical Imaging Upstart AZmed Raises €15 Million in Series A Financing**
French health tech startup AZmed has recently announced that it has successfully secured €15 million in its Series A funding round, with investors including prominent financial institution Maison Worms, Techstars, and Tempact Ventures. This milestone signifies a significant step forward for the company, which is dedicated to AI-powered medical imaging technology.
AZmed’s flagship product is the AI software called Rayvolve, designed as an auxiliary diagnostic tool specifically for identifying various anomalies in standard radiographs. By leveraging advanced AI algorithms, Rayvolve aids radiologists and emergency physicians in interpreting images more swiftly and accurately, enhancing the efficiency of medical examinations and reducing the risk of diagnostic errors due to human factors.
According to technology news platform Tech.eu, the funds will primarily be used to accelerate Rayvolve’s technological development and market expansion, as well as broaden the company’s service offerings to cater to the growing global demand for efficient and precise diagnostic tools. AZmed’s innovative approach foreshadows a broader adoption of AI in healthcare, potentially ushering in a transformative shift in the industry.
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 1